Free Trial
ASX:ZLD

Zelira Therapeutics (ZLD) Stock Price, News & Analysis

About Zelira Therapeutics Stock (ASX:ZLD)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
311,821 shs
Average Volume
N/A
Market Capitalization
A$5.79 million
P/E Ratio
N/A
Dividend Yield
8.62%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive ZLD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Zelira Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

ZLD Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com

ZLD Stock Analysis - Frequently Asked Questions

Zelira Therapeutics Limited (ASX:ZLD) released its quarterly earnings results on Friday, February, 22nd. The company reported $0.00 EPS for the quarter. Zelira Therapeutics had a negative net margin of 38,513.04% and a positive trailing twelve-month return on equity of 1,066.85%.

Based on aggregate information from My MarketBeat watchlists, some other companies that Zelira Therapeutics investors own include Milestone Pharmaceuticals (MIST), Ovintiv (OVV), SIG (SHI), Allena Pharmaceuticals (ALNA), Alpine Immune Sciences (ALPN), Affiliated Managers Group (AMG) and ARAVIVE (ARAV).

Company Calendar

Last Earnings
2/22/2019
Today
8/14/2025

Industry, Sector and Symbol

Stock Exchange
ASX
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
ASX:ZLD
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
A($3.22)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-A$36.57 million
Net Margins
-38,513.04%
Pretax Margin
N/A
Return on Equity
1,066.85%
Return on Assets
-18.87%

Debt

Debt-to-Equity Ratio
-131.77
Current Ratio
0.60
Quick Ratio
1.85

Sales & Book Value

Annual Sales
A$1.54 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
23.00
Book Value
A($0.37) per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
11,350,000
Free Float
N/A
Market Cap
A$5.79 million
Optionable
Not Optionable
Beta
0.83
7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

This page (ASX:ZLD) was last updated on 8/15/2025 by MarketBeat.com Staff
From Our Partners